Search

Search Constraints

You searched for: Author/Creator Crivera, Concetta

Search Results

3. Importance of balancing follow-up time and impact of oral-anticoagulant users' selection when evaluating medication adherence in atrial fibrillation patients treated with rivaroxaban and apixaban. (3rd June 2017)

4. Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin. (29th January 2019)

6. Cost comparison of continued anticoagulation with rivaroxaban versus placebo based on the 1-year EINSTEIN-Extension trial efficacy and safety results. (3rd June 2018)

7. Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status. Issue 1 (January 2017)

9. Outcomes associated with observation status versus inpatient management of pulmonary embolism patients anticoagulated with rivaroxaban. (1st November 2016)

10. Comparative effectiveness of ciltacabtagene autoleucel in CARTITUDE‐1 versus physician's choice of therapy in the Flatiron Health multiple myeloma cohort registry for the treatment of patients with relapsed or refractory multiple myeloma. Issue 1 (10th December 2021)